Location:

China News

Add to Favorites Subscribe Share
Newswise: Partnership with China Prompts Change in Care for High-Risk Type of Leukemia
  • Embargo expired:
    16-Jan-2020 11:00 AM EST

Partnership with China Prompts Change in Care for High-Risk Type of Leukemia

St. Jude Children's Research Hospital

Researchers from St. Jude Children’s Research Hospital and the Chinese Children’s Cancer Group led the first randomized, Phase III clinical trial comparing targeted therapies for acute lymphoblastic leukemia (ALL) driven by the Philadelphia chromosome. Results showed that the drug dasatinib provides more benefit than the standard of care, which led to changes in the way this leukemia is treated. The findings were reported today in JAMA Oncology.

Channels: Cancer, Children's Health, Clinical Trials, China News, Blood, JAMA, All Journal News,

Released:
14-Jan-2020 12:00 PM EST
Research Alert
Newswise: Robotic Gripping Mechanism Mimics How Sea Anemones Catch Prey

Robotic Gripping Mechanism Mimics How Sea Anemones Catch Prey

American Institute of Physics (AIP)

Researchers in China demonstrated a robotic gripping mechanism that mimics how a sea anemone catches its prey. The bionic torus captures and releases objects by crimping its skin. The grasper not only is relatively cheap and easy to produce but also can grab a variety of objects of different sizes, shapes, weights and materials. They discuss their work in this week’s Applied Physics Letters.

Channels: Engineering, Marine Science, Physics, Technology, China News, All Journal News,

Released:
14-Jan-2020 1:55 PM EST
Expert Pitch


0.79087